ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 117 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $705,000 | -1.7% | 482,962 | -4.3% | 0.00% | 0.0% |
| Q4 2016 | $717,000 | -21.0% | 504,662 | -2.8% | 0.00% | -50.0% |
| Q3 2016 | $908,000 | +3.3% | 518,962 | +0.9% | 0.00% | 0.0% |
| Q2 2016 | $879,000 | -13.0% | 514,162 | +0.3% | 0.00% | 0.0% |
| Q1 2016 | $1,010,000 | +18.5% | 512,737 | +14.3% | 0.00% | 0.0% |
| Q4 2015 | $852,000 | +1.3% | 448,544 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $841,000 | -59.0% | 440,564 | -0.4% | 0.00% | -60.0% |
| Q2 2015 | $2,052,000 | +6.2% | 442,264 | +0.0% | 0.01% | 0.0% |
| Q1 2015 | $1,933,000 | +36.8% | 442,243 | +8.6% | 0.01% | +66.7% |
| Q4 2014 | $1,413,000 | -16.8% | 407,243 | +0.4% | 0.00% | -25.0% |
| Q3 2014 | $1,699,000 | -27.7% | 405,510 | +1.1% | 0.00% | -33.3% |
| Q2 2014 | $2,350,000 | -5.8% | 401,008 | +1.3% | 0.01% | -14.3% |
| Q1 2014 | $2,494,000 | +8.2% | 395,808 | +0.4% | 0.01% | +16.7% |
| Q4 2013 | $2,306,000 | +11.7% | 394,108 | +0.6% | 0.01% | 0.0% |
| Q3 2013 | $2,064,000 | -29.4% | 391,608 | +3.2% | 0.01% | -33.3% |
| Q2 2013 | $2,922,000 | -5.6% | 379,493 | +0.7% | 0.01% | -10.0% |
| Q1 2013 | $3,095,000 | – | 376,970 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 10,500,000 | $17,955,000 | 0.87% |
| SENZAR ASSET MANAGEMENT, LLC | 1,872,191 | $3,201,447,000 | 0.70% |
| Virtus ETF Advisers LLC | 277,607 | $475,000 | 0.35% |
| GLOBEFLEX CAPITAL L P | 571,500 | $977,000 | 0.27% |
| Lyons Wealth Management, LLC. | 42,408 | $73,000 | 0.11% |
| TFS CAPITAL LLC | 222,736 | $381,000 | 0.07% |
| Jacobi Capital Management LLC | 35,000 | $56,000 | 0.03% |
| Renaissance Technologies | 5,601,355 | $9,578,000 | 0.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 26,725,936 | $45,701,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 46,300 | $79,000 | 0.01% |